NBI-6024
- Generic Name
- NBI-6024
- Drug Type
- Biotech
- Unique Ingredient Identifier
- OMF3CT7D4L
- Background
NBI-6024 is an altered peptide ligand that is designed to cause an immune response which result in preservation of beta-cell function and endogenous insulin production.
- Indication
Investigated for use/treatment in diabetes mellitus type 1 and pediatric indications.
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath